GlaxoSmithKline PLC (NYSE:GSK)

33.82
BATS BZX Real-Time Price
As of 9:34am ET
 +0.21 / +0.62%
Today’s Change
31.43
Today|||52-Week Range
43.39
-8.10%
Year-to-Date
Better Buy: Veeva Systems or Teladoc?
Feb 27 / MotleyFool.com - Paid Partner Content
RedHill (RDHL) Doses First Patient in Phase II/III COVID-19 Study
Feb 19 / Zacks.com - Paid Partner Content
Why AnaptysBio Was a Stock Market Star on Friday
Feb 26 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: Coronavirus Vaccine Updates From PFE, AZN & JNJ
Feb 19 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: SNY/GSK & PFE COVID-19 Vaccine Update, MRK's Pandion Buyout
Feb 26 / Zacks.com - Paid Partner Content
Glaxo (GSK)/Vir Biotech to Develop Antibodies for Influenza
Feb 18 / Zacks.com - Paid Partner Content
Theravance (TBPH) Q4 Earnings Top Estimates, Revenues In Line
Feb 24 / Zacks.com - Paid Partner Content
Vir Biotechnology and GlaxoSmithKline Expand Their Partnership
Feb 17 / MotleyFool.com - Paid Partner Content
Here's the Scoop on the Biggest Healthcare SPAC Deal So Far
Feb 21 / MotleyFool.com - Paid Partner Content
Why Vir Biotechnology Stock Is Higher Today
Feb 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close33.61
Today’s open33.87
Day’s range33.82 - 33.89
Volume264,831
Average volume (3 months)5,668,845
Market cap$84.5B
Data as of 9:34am ET, 03/01/2021

Growth & Valuation

Earnings growth (last year)+23.68%
Earnings growth (this year)-11.65%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)+1.55%
P/E ratio9.5
Price/Sales2.12
Price/Book4.20

Competitors

----
ZTSZoetis Inc+1.39+0.90%
----
----
Data as of 9:33am ET, 03/01/2021

Financials

Next reporting dateApril 28, 2021
EPS forecast (this quarter)$0.72
Annual revenue (last year)$43.7B
Annual profit (last year)$7.4B
Net profit margin16.86%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Middlesex, Greater London

Forecasts